Product
Naltrexone and Bupropion
2 clinical trials
3 indications
Indication
binge eating disorderIndication
ObesityIndication
Binge Eating DisorderClinical trial
Pharmacological and Behavioral Treatments to Treat Loss-of-Control Eating and Improve Weight Outcomes After Bariatric Surgery: Maintenance Treatment (Stage 2a)Status: , Estimated PCD: 2027-05-01
Clinical trial
Cognitive-Behavioral and Pharmacologic Treatment of Binge-Eating Disorder and ObesityStatus: Terminated, Estimated PCD: 2023-12-14